Kenneth Bate, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 39,400 shares at $351.99 ($14.0M) on 2025-02-27, disclosed to the SEC on 2025-02-28.
Open-market sale of $14.0M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $351.01 | 100 | $35K | 0.2% |
| 2 | $351.99 | 500 | $176K | 1.3% |
| 3 | $353.83 | 238 | $84K | 0.6% |
| 4 | $353.83 | 238 | $84K | 0.6% |
| 5 | $355.08 | 8,545 | $3.0M | 21.6% |
| 6 | $355.08 | 8,545 |
| $3.0M |
| 21.6% |
| 7 | $356.51 | 2,791 | $995K | 7.1% |
| 8 | $356.51 | 2,791 | $995K | 7.1% |
| 9 | $357.27 | 2,038 | $728K | 5.2% |
| 10 | $357.27 | 2,038 | $728K | 5.2% |
| 11 | $358.33 | 3,548 | $1.3M | 9.1% |
| 12 | $358.33 | 3,548 | $1.3M | 9.1% |
| 13 | $359.21 | 2,024 | $727K | 5.2% |
| 14 | $359.21 | 2,024 | $727K | 5.2% |
| 15 | $360.07 | 216 | $78K | 0.6% |
| 16 | $360.07 | 216 | $78K | 0.6% |
| Total | $356.51 avg | 39,400 | $14.0M | 100% |
| Filing → |
| MDGL | SELL | 2024-04-03 | $16.0M | — | Filing → |
| CBST | SELL | 2014-02-04 | $451K | — | Filing → |
| CBST | SELL | 2014-01-09 | $700K | — | Filing → |